OPAL

Registerplattform Mammakarzinom-OPAL:
Treatment and Outcome of Patients with Advanced breast cancer: cLinical research platform for real world data (OPAL)
Specifications
-
Sponsor: iOMEDICO, Freiburg, Germany
iOM-P0361
Registerplattform Mammakarzinom-OPAL:
Treatment and Outcome of Patients with Advanced breast cancer: cLinical research platform for real world data (OPAL)
Sponsor: iOMEDICO, Freiburg, Germany
iOM-P0361
Internisten • Hämatologen • Onkologen • Palliativmedizin • Onkologische Tagesklinik
Onkologische Zentren
Prof. (SHB) Dr. med. Dirk Hempel